102 related articles for article (PubMed ID: 28765951)
1. Pseudolaric acid B inhibits neuroglioma cell proliferation through DNA damage response.
Song F; Yu X; Zhang H; Wang Z; Wang Y; Meng X; Yu J
Oncol Rep; 2017 Oct; 38(4):2211-2218. PubMed ID: 28765951
[TBL] [Abstract][Full Text] [Related]
2. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
[TBL] [Abstract][Full Text] [Related]
3. Pseudolaric acid B inhibits the secretion of hepatitis B virus.
Yu J; Wang Z; Ren P; Zhong T; Wang Y; Song F; Hou J; Yu X; Hua S
Oncol Rep; 2017 Jan; 37(1):519-525. PubMed ID: 27878296
[TBL] [Abstract][Full Text] [Related]
4. Pseudolaric acid B induces apoptosis in human rhabdomyosarcoma RD cells.
Liu C; Wang F; Wang B; Wu T; Wang Y; Huo W; Zhang S; Su Y; Liu J; Liu Y; Yu J
Oncol Lett; 2020 Dec; 20(6):358. PubMed ID: 33133258
[TBL] [Abstract][Full Text] [Related]
5. ATM-p53 pathway causes G2/M arrest, but represses apoptosis in pseudolaric acid B-treated HeLa cells.
Yao G; Qi M; Ji X; Fan S; Xu L; Hayashi T; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2014 Sep; 558():51-60. PubMed ID: 24929187
[TBL] [Abstract][Full Text] [Related]
6. Pseudolaric acid B exerts antitumor activity via suppression of the Akt signaling pathway in HeLa cervical cancer cells.
Li M; Hong L
Mol Med Rep; 2015 Aug; 12(2):2021-6. PubMed ID: 25891953
[TBL] [Abstract][Full Text] [Related]
7. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
[TBL] [Abstract][Full Text] [Related]
8. Activation of p53 contributes to pseudolaric acid B-induced senescence in human lung cancer cells in vitro.
Yao GD; Yang J; Li Q; Zhang Y; Qi M; Fan SM; Hayashi T; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2016 Jul; 37(7):919-29. PubMed ID: 27041461
[TBL] [Abstract][Full Text] [Related]
9. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells.
Yu JH; Wang HJ; Li XR; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2008 Sep; 29(9):1069-76. PubMed ID: 18718176
[TBL] [Abstract][Full Text] [Related]
11. Pseudolaric Acid B Induces Growth Inhibition and Caspase-Dependent Apoptosis on Head and Neck Cancer Cell lines through Death Receptor 5.
Choi SJ; Ahn CH; Yang IH; Jin B; Lee WW; Kim JH; Ahn MH; Swarup N; Hong KO; Shin JA; Woo NT; Hong SD; Lee JI; Cho SD
Molecules; 2019 Oct; 24(20):. PubMed ID: 31623058
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of LC-MS/MS method for quantification of pseudolaric acid B from the root bark of Pseudolarix kaempferi in rat plasma: application to a pharmacokinetic study.
Wang H; Wang Y; Feng X; Suo J; Zhang N
J Pharm Biomed Anal; 2015 Apr; 108():56-60. PubMed ID: 25710903
[TBL] [Abstract][Full Text] [Related]
13. Pseudolaric acid B induces endometrial cancer Ishikawa cell apoptosis and inhibits metastasis through AKT-GSK-3β and ERK1/2 signaling pathways.
Wang D; Tian Y; Feng W; Zhao L; Zhao M; Liu J; Wang Q
Anticancer Drugs; 2017 Jul; 28(6):603-612. PubMed ID: 28422767
[TBL] [Abstract][Full Text] [Related]
14. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT.
Wang Z; Ding Y; Wang X; Lu S; Wang C; He C; Wang L; Piao M; Chi G; Luo Y; Ge P
Cancer Lett; 2018 Aug; 428():21-33. PubMed ID: 29702192
[TBL] [Abstract][Full Text] [Related]
15. Pseudolaric acid B induces caspase-dependent cell death in human ovarian cancer cells.
Yu B; Yue DM; Shu LH; Li NJ; Wang JH
Oncol Rep; 2014 Feb; 31(2):849-57. PubMed ID: 24276652
[TBL] [Abstract][Full Text] [Related]
16. [Pseudolaric acid B induces G2/M arrest and inhibits invasion and migration in HepG2 hepatoma cells].
Li S; Guo L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):59-64. PubMed ID: 29595459
[TBL] [Abstract][Full Text] [Related]
17. Role of pseudolaric acid B in A549 lung cancer cell proliferation and apoptosis.
Guan T; Yang Y
Mol Med Rep; 2014 Jan; 9(1):144-8. PubMed ID: 24248012
[TBL] [Abstract][Full Text] [Related]
18. Pseudolaric acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K/AKT, ERK1/2 and mitochondria-mediated apoptosis pathways.
Wang D; Xin Y; Tian Y; Li W; Sun D; Yang Y
Exp Cell Res; 2017 Mar; 352(1):34-44. PubMed ID: 28132880
[TBL] [Abstract][Full Text] [Related]
19. Blocking the utilization of glucose induces the switch from senescence to apoptosis in pseudolaric acid B-treated human lung cancer cells in vitro.
Yao GD; Yang J; Li XX; Song XY; Hayashi T; Tashiro SI; Onodera S; Song SJ; Ikejima T
Acta Pharmacol Sin; 2017 Oct; 38(10):1401-1411. PubMed ID: 28649131
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid B.
Ma G; Chong L; Li XC; Khan IA; Walker LA; Khan SI
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1333-40. PubMed ID: 20140742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
